Effects of a Lytic Peptide Conjugated to hCG on Ovarian Cancer: Studies in Vitro and in Vivo

Author： Gawronska B.   Leuschner C.   Enright F.M.   Hansel W.  

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.85, Iss.1, 2002-04, pp. : 45-52

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Smac peptide potentiates TRAIL- or paclitaxel-mediated ovarian cancer cell death in vitro and in vivo

By              

Oncology Reports, Vol. 29, Iss. 2, 2013-01 ,pp. : 515-522

Spandidos Publications

Access to resources Recommend Favorite

Cytotoxic properties of immunoconjugates containing melittin-like peptide 101 against prostate cancer: in vitro and in vivo studies

By Russell Pamela   Hewish Dean   Carter Teresa   Sterling-Levis Katy   Ow Kim   Hattarki Meghan   Doughty Larissa   Guthrie Robin   Shapira Deborah   Molloy Peter   Werkmeister Jerome   Kortt Alexander  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 5, 2004-05 ,pp. : 411-421

Springer Publishing Company

Access to resources Recommend Favorite

Glucose Oxidase Conjugated with Anti-endothelial Monoclonal Antibodies: in Vitro and in Vivo Studies

By Muzykantov V.R.   Danilov S.M.  

International Journal of Radiation Biology, Vol. 60, Iss. 1-2, 1991-07 ,pp. : 11-15

Informa Healthcare

Access to resources Recommend Favorite

Efficacy of a synthetic lytic peptide in the treatment of prostate cancer

By Arlotti J.A.   Cimino T.S.   Nguyen T.-S.   Dhir R.   Thomas A.   Jaynes J.M.   Caldwell A.L.   Getzenberg R.H.  

Urologic Oncology: Seminars and Original Investigations, Vol. 6, Iss. 3, 2001-05 ,pp. : 97-102

Elsevier

Access to resources Recommend Favorite

TOFA suppresses ovarian cancer cell growth in vitro and in vivo

By                

Molecular Medicine Reports, Vol. 8, Iss. 2, 2013-01 ,pp. : 373-378

Spandidos Publications

Access to resources Recommend Favorite